Virtu KCG Holdings LLC Takes Position in STAAR Surgical Company (STAA)

Virtu KCG Holdings LLC bought a new position in shares of STAAR Surgical Company (NASDAQ:STAA) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 10,955 shares of the medical instruments supplier’s stock, valued at approximately $118,000.

Several other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of STAAR Surgical by 0.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,280,775 shares of the medical instruments supplier’s stock worth $13,832,000 after buying an additional 7,803 shares in the last quarter. Northern Trust Corp increased its stake in shares of STAAR Surgical by 5.2% during the 2nd quarter. Northern Trust Corp now owns 481,459 shares of the medical instruments supplier’s stock worth $5,199,000 after purchasing an additional 23,764 shares during the last quarter. Menta Capital LLC increased its stake in shares of STAAR Surgical by 11.3% during the 2nd quarter. Menta Capital LLC now owns 206,321 shares of the medical instruments supplier’s stock worth $2,228,000 after purchasing an additional 20,913 shares during the last quarter. New York State Common Retirement Fund increased its stake in shares of STAAR Surgical by 26.2% during the 2nd quarter. New York State Common Retirement Fund now owns 44,800 shares of the medical instruments supplier’s stock worth $484,000 after purchasing an additional 9,299 shares during the last quarter. Finally, Teachers Advisors LLC increased its stake in shares of STAAR Surgical by 13.5% during the 2nd quarter. Teachers Advisors LLC now owns 84,044 shares of the medical instruments supplier’s stock worth $908,000 after purchasing an additional 10,000 shares during the last quarter. 76.68% of the stock is currently owned by hedge funds and other institutional investors.

STAA has been the subject of a number of recent research reports. Benchmark Co. lifted their price objective on shares of STAAR Surgical from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Monday, August 14th. Canaccord Genuity restated a “buy” rating and set a $15.00 price target on shares of STAAR Surgical in a research report on Sunday, October 8th. Zacks Investment Research raised shares of STAAR Surgical from a “hold” rating to a “buy” rating and set a $12.00 price objective for the company in a report on Saturday, September 23rd. TheStreet raised shares of STAAR Surgical from a “d+” rating to a “c” rating in a report on Tuesday, August 15th. Finally, BidaskClub raised shares of STAAR Surgical from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $14.00.

STAAR Surgical (NASDAQ:STAA) last released its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported ($0.01) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.05) by $0.04. STAAR Surgical had a negative net margin of 6.06% and a negative return on equity of 8.69%. The business had revenue of $21.90 million during the quarter, compared to analyst estimates of $22.15 million. During the same quarter last year, the business earned ($0.02) earnings per share. STAAR Surgical’s quarterly revenue was up 4.8% compared to the same quarter last year.

WARNING: This story was reported by Community Financial News and is owned by of Community Financial News. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://www.com-unik.info/2017/11/02/virtu-kcg-holdings-llc-takes-position-in-staar-surgical-company-staa.html.

STAAR Surgical Profile

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical Company (NASDAQ:STAA).

Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

What are top analysts saying about STAAR Surgical Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for STAAR Surgical Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit